drugset / Trial / NCT01316107
A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate long-term safety and efficacy after concomitant administration of ASP1941 and Nateglinide inhibitor in Japanese patients with type 2 diabetes mellitus.
Timeline
- Start
- 2011-01-15
- Primary completion
- 2012-10-19
- Completion
- 2012-10-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ipragliflozin | Small molecule | — | Oral |
| Background | Nateglinide | Small molecule | — | Oral |